Travere Therapeutics, Inc.
TVTX
$17.92
$0.130.73%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 319.54M | 322.24M | 370.70M | 277.44M | 325.40M |
| Total Receivables | 40.22M | 36.48M | 29.42M | 27.67M | 27.27M |
| Inventory | 4.09M | 3.93M | 6.20M | 6.36M | 5.98M |
| Prepaid Expenses | 15.72M | 11.52M | 10.39M | 13.28M | 10.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 379.57M | 374.17M | 416.70M | 324.74M | 368.98M |
|
|
|||||
| Total Current Assets | 379.57M | 374.17M | 416.70M | 324.74M | 368.98M |
| Net Property, Plant & Equipment | 16.90M | 18.05M | 19.63M | 21.82M | 23.05M |
| Long-term Investments | 753.00K | 753.00K | 753.00K | 747.00K | 753.00K |
| Goodwill | 753.00K | 753.00K | 753.00K | 747.00K | 753.00K |
| Total Other Intangibles | 104.85M | 103.06M | 103.22M | 103.46M | 104.42M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.24M | 52.76M | 53.82M | 53.64M | 53.92M |
| Total Assets | 555.31M | 548.80M | 594.13M | 504.41M | 551.12M |
|
|
|||||
| Total Accounts Payable | 19.13M | 15.37M | 23.53M | 23.20M | 25.84M |
| Total Accrued Expenses | 81.68M | 77.11M | 86.03M | 83.56M | 78.59M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 74.43M | 74.22M | 74.08M | 73.90M | 5.16M |
| Total Finance Division Other Current Liabilities | 14.29M | 15.76M | 17.11M | 9.39M | 11.68M |
| Total Other Current Liabilities | 14.29M | 15.76M | 17.11M | 9.39M | 11.68M |
| Total Current Liabilities | 189.54M | 182.46M | 200.75M | 190.04M | 121.27M |
|
|
|||||
| Total Current Liabilities | 189.54M | 182.46M | 200.75M | 190.04M | 121.27M |
| Long-Term Debt | 311.02M | 310.66M | 310.31M | 309.96M | 378.13M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.12M | 15.58M | 17.19M | 18.58M | 19.94M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.88M | 7.27M | 6.80M | 16.29M | 16.64M |
| Total Liabilities | 522.56M | 515.98M | 535.05M | 534.86M | 535.97M |
|
|
|||||
| Common Stock & APIC | 1.53B | 1.52B | 1.51B | 1.36B | 1.35B |
| Retained Earnings | -1.50B | -1.49B | -1.45B | -1.39B | -1.33B |
| Treasury Stock & Other | -812.00K | -843.00K | -80.00K | -1.02M | -1.63M |
| Total Common Equity | 32.75M | 32.82M | 59.08M | -30.45M | 15.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 32.75M | 32.82M | 59.08M | -30.45M | 15.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 32.75M | 32.82M | 59.08M | -30.45M | 15.15M |
|
|
|||||